Chronic Illness and Inflammation: Conditions such as diabetes, autoimmune disorders, heart disease, and chronic infections significantly reduce glutathione levels
It is studied as a KLOW 80mg peptide blend for multi-pathway research bringing tissue-repair, angiogenic, and anti-inflammatory peptides together at fixed ratios so a research model can be exposed to all four compounds at once, without reconstituting four separate vials
GLP-1s suppress appetite broadly, meaning protein intake tends to fall along with total calorie intake
also showed that a combination supplement containing multivitamins, zinc, thiamine, ergocalciferol, pyridoxine, and, carnitine helped improve the treatment of elderly patients with COVID-19 [39]
Results of these trials showed GLP-1 agonists have a favorable safety profile, with most side effects being mild and temporary